Home

Welcome to Duke Health
Government Relations.

Duke Health Government Relations works to build and strengthen relationships with policy makers and others whose understanding and support are vital to Duke Health. Our office is the primary liaison between Duke Health and the U.S. Congress and the Executive Branch. We facilitate the development, implementation, and advocacy of Duke Health's federal agenda. Learn More

Our office continues to engage lawmakers in Congress on key health care issues impacting Duke. Check out our Resources page for links to how you can find your rep!

Policy Insights

The Intersection of Research and Federal Policy

Hematology/oncology fellow Ryne Ramaker (left), and clinician Jim Abbruzzese aim to translate a potential early diagnostic test for pancreatic cancer from the lab to the clinic. Photo by Les Todd. In Search of Early Diagnosis on Pancreatic Cancer

This research received support from the National Cancer Institute.

A new study finds that race is important to consider when evaluating stroke-related communication disorders. (Photo courtesy of Duke Health) A Person’s Race Influences Question Asking as Much as Their Stroke History

Research support came from the U.S. National Institute on Deafness and Other Communication Disorders, the U.S. National Institutes of Health Office of Research on Women’s Health, and the U.S. National Institute on Minority Health and Health Disparities.

A yellow ribbon, an emblem for suicide prevention awareness Four Genes Identified as Heightening Risk of Suicidal Thoughts/Actions

This research received support from the Clinical Science Research and Development Service of the Veterans Health Administration, the U.S. Department of Veterans Affairs, and the U.S. Department of Energy.

Meira Epplein, PhD, associate professor in population health sciences and medicine, and Katherine Garman, MD, MHS, associate professor of medicine Mission: Interception — Creating Better Ways to Stop Cancer in Its Tracks

The Duke Cancer Institute obtained National Cancer Institute approval for the new CRDI program in 2021 to focus on research that falls somewhere between cancer prevention and treatment.